首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer medicine

缩写:CANCER MED-US

ISSN:2045-7634

e-ISSN:2045-7634

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引8518
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Szu-Yu Zoe Kao,Maria X Sanmartin,Judy Yee et al. Szu-Yu Zoe Kao et al.
Background: Given the Centers for Medicare and Medicaid Services' coverage of screening CT colonography (CTC) beginning in January 2025, we evaluated the cost-effectiveness of CTC for colorectal cancer (CRC) screening by ...
Nicolette I Teufel-Shone,Kelly A Laurila,Julie S Armin et al. Nicolette I Teufel-Shone et al.
Aim: The Outreach Core of the Partnership for Native American Cancer Prevention (NACP) in Arizona offers an overview of strategies designed to (1) provide cancer-related education in collaboration with Native Nations and ...
Michael J Rovito,Khushi M Chauhan,Humnah Baig Michael J Rovito
Background: Cancer-related cognitive impairment (CRCI), commonly known as chemobrain, is characterized by deficits in memory, processing speed, and executive function. While traditionally linked to chemotherapy, emerging ...
Preeti Borde,Alia Abdulla,Ebrahim Rajab et al. Preeti Borde et al.
Background: Treatment benefits of paclitaxel (Px)-based chemotherapy are often offset by dose-limiting side effects. The sigma-1 receptor (Sig1R) is implicated in chemotherapy (ChT)-induced neuropathy but its role in the ...
Yi-Yang Jiang,Min-Min Yu,Xia Cui et al. Yi-Yang Jiang et al.
Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality, characterized by a poor prognosis. The advent of immunotherapy has significantly altered the treatment landscape for NSCLC. ...
Simon J Fifer,Karen Winkler,Meredith Cummins et al. Simon J Fifer et al.
Background: Long-acting somatostatin analogues (LA SSAs) are commonly used as first-line treatment in well-differentiated low and intermediate grade 1-2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs). As a long-...
Heng Liu,Junrong Yan,Junjun He et al. Heng Liu et al.
Background: Circulating tumor DNA (ctDNA) provides a noninvasive method to clarify patients' genomic alterations. This study evaluated plasma-derived ctDNA before second-line osimertinib administration to explore the rela...
Carolyn S Harris,Kord M Kober,Joosun Shin et al. Carolyn S Harris et al.
Background: Inflammation is associated with sickness behavior symptoms in patients receiving chemotherapy. However, its impact on symptom burden (i.e., higher number of concurrent symptoms) requires evaluation. Study purp...
Yongzhe Wang,Christine M Quinones,Elizabeth Gonzalez et al. Yongzhe Wang et al.
Introduction: Timely treatment initiation is critical to clinical outcomes in breast cancer (BC). While social determinants of health are established drivers of disparities in the timeliness of care (ToC), the impact of t...
Xia Cao,Duanzong Zhang,Jichang Gong et al. Xia Cao et al.
Background: Burkitt lymphoma (BL) in middle-aged and elderly populations presents unique prognostic challenges due to distinct biological behaviors and therapeutic vulnerabilities. Current prognostic tools inadequately ad...